Moorjani S, Roy M, Gagne C, Davignon J, Brun D, Toussaint M, Lambert M, Campeau L, Blaichman S, Lupien P. 1989. Homozygous familial hypercholesterolemia among French Canadians in Quebec Province. Arteriosclerosis 9(2):211-216.

Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM. 2006. The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions. Journal of Pharmacology and Experimental Therapeutics 316(1):336-348.

Pirmohamed M, Park BK. 2001. Genetic susceptibility to adverse drug reactions. Trends in Pharmacological Sciences 22(6):298-305.

Pritchard JK, Rosenberg NA. 1999. Use of unlinked genetic markers to detect population stratification in association studies. American Journal of Human Genetics 65(1):220-228.

Quinn CT, Miller ST. 2004. Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia. Hematology/Oncology Clinics of North America 18(6 SPEC.ISS.):1339-1354.

Rebbeck TR, Walker AH, Phelan CM, Godwin AK, Buetow KH, Garber JE, Narod SA, Weber BL. 1997. Defining etiologic heterogeneity in breast cancer using genetic biomarkers. Progress in Clinical and Biological Research 396:53-61.

Rimoin DL, Connor JM, Pyeritz RE, Korf BR, editors. 2002. Emery and Rimoin’s Principles and Practice of Medical Genetics Vol. 2. 4th edition. New York: Churchill Livingstone.

Risch NJ. 2000. Searching for genetic determinants in the new millennium. Nature 405(6788): 847-856.

Satten GA, Flanders WD, Yang Q. 2001. Accounting for unmeasured population substructure in case-control studies of genetic association using a novel latent-class model. American Journal of Human Genetics 68(2):466-477.

Sing CF, Stengard JH, Kardia SLR. 2003. Genes, environment, and cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology 23:1190-1196.

Smith, G. 2005. The Genomics Age: How DNA Technology Is Transforming the Way We Live and Who We Are. New York: AMACOM.

Steinberg MH. 2005. Predicting clinical severity in sickle cell anaemia. British Journal of Haematology 129(4):465-481.

Stuart MJ, Nagel RL. 2004. Sickle-cell disease. Lancet 364(9442):1343-1360.

Syvanen AC. 2005. Toward genome-wide SNP genotyping. Nature Genetics (37 Suppl):S5-S10.

Thompson MW, McInnes RR, Willard, editors. 1991. Thompson & Thompson Genetics in Medicine. 5th edition. Philadelphia, PA: W.B. Saunders Company.

Wacholder S, Rothman N, Caporaso N. 2000. Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias. Journal of the National Cancer Institute 92(14):1151-1158.

Wang X, Tomso DJ, Liu X, Bell DA. 2005. Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicology and Applied Pharmacology 207(2 Suppl):84-90.

Wang Z, Fan H, Yang HH, Hu Y, Buetow KH, Lee MP. 2004. Comparative sequence analysis of imprinted genes between human and mouse to reveal imprinting signatures. Genomics 83(3):395-401.

Weinshilboum R. 2003. Inheritance and drug response. New England Journal of Medicine 348(6):529-537.

Wu JH, Lo SK, Wen MS, Kao JT. 2002. Characterization of apolipoprotein E genetic variations in Taiwanese association with coronary heart disease and plasma lipid levels. Human Biology 74(1)25-31.

Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. 2003. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiology, Biomarkers and Prevention 12(4):359-365.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement